We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Two Renowned Vaccine Experts Joining Themis Bioscience GmbH

News   Jan 21, 2016

 
Two Renowned Vaccine Experts Joining Themis Bioscience GmbH
 
 
 

RELATED ARTICLES

Clinical Trial Assessing Treatments for Preventing People at High Risk From Developing Multidrug-resistant TB Launches

News

A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB drug isoniazid for preventing active MDR-TB disease in children, adolescents and adults at high risk who are exposed to adult household members with MDR-TB.

READ MORE

Understanding Immune Cell Recruitment Key to STI Vaccine Development

News

In a study published in Nature Communications, researchers from King’s have shown how skin vaccination can generate protective CD8 T-cells that are recruited to the genital tissues and could be used as a vaccination strategy for sexually transmitted infections.

READ MORE

Kitchen Sponges Host Bacteria-fighting Microbes

News

Kitchen sponges have been found to host viruses that infect bacteria, called bacteriophages. As the threat of antibiotic resistance increases, bacteriophages, or phages for short, may prove useful in fighting bacteria that cannot be killed by antibiotics alone,

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE